Return to search

Cellerix Raises Second Round

Cellerix SL, a Tres Cantos, Spain-based developer of adult stem cell therapies, has raised EUR 27.2 million in new VC funding. Life Sciences Partners and Ventech co-led the round, and were joined by Roche Venture Fund, Novartis Venture Fund and Ysios Capital Partners. Return backers included former parent company Genetrix and Grupo A&G. www.cellerix.com